Tissue plasminogen activator for the treatment of intraabdominal abscesses in a neonate.

[1]  O. Rotstein.  Role of fibrin deposition in the pathogenesis of intraabdominal infection , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[2]  J. Yee,et al.  Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  S. Silverman,et al.  Intracavitary urokinase for enhancement of percutaneous abscess drainage: phase II trial. , 2000, AJR. American journal of roentgenology.

[4]  I. Kelly,et al.  Adjuvant urokinase therapy in percutaneous drainage of a multiloculated splenic abscess. , 1999, Journal of vascular and interventional radiology : JVIR.

[5]  B. A. Mueller,et al.  Intraperitoneal Thrombolytic Therapy for Peritoneal Dialysis–Associated Peritonitis , 1998, The Annals of pharmacotherapy.

[6]  Y. Sivan,et al.  Treatment of loculated pleural effusion with intrapleural urokinase in children. , 1997, Journal of pediatric surgery.

[7]  H. van Goor,et al.  Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator. , 1995, Journal of the American College of Surgeons.

[8]  J. van der Meer,et al.  Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis. , 1994, Journal of the American College of Surgeons.

[9]  J. Haaga,et al.  Fluid flow during percutaneous drainage procedures: an in vitro study of the effects of fluid viscosity, catheter size, and adjunctive urokinase. , 1993, AJR. American journal of roentgenology.

[10]  J. Haaga,et al.  Safety of intracavitary urokinase with percutaneous abscess drainage. , 1993, AJR. American journal of roentgenology.

[11]  R. W. Holden,et al.  Plasminogen activators: pharmacology and therapy. , 1990, Radiology.

[12]  D. McRitchie,et al.  Tissue plasminogen activator reverses the deleterious effect of infection on colonic wound healing. , 1990, Annals of surgery.

[13]  D. McRitchie,et al.  Delayed administration of tissue plasminogen activator reduces intra-abdominal abscess formation. , 1989, Archives of surgery.

[14]  O. Rotstein,et al.  Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator. , 1988, The Journal of infectious diseases.

[15]  Simmons Rl,et al.  Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. , 1980 .